A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
Study Details
Study Description
Brief Summary
To compare the effects of megestrol acetate and placebo on body weight, anorexia, cachexia, calorie intake, and nutritional parameters of patients with a confirmed diagnosis of AIDS. To determine whether megestrol acetate relative to placebo improves the perception of well-being among AIDS patients with cachexia. To evaluate megestrol acetate's effect on immune function via skin test reactivity, T4/T8 ratio, and total lymphocytes.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria
Patient must have:
-
Confirmed diagnosis of AIDS (CDC definition).
-
Documented weight loss or anorexia.
-
Life expectancy = or > 20 weeks.
-
The perception that the weight loss is a detriment to their well-being.
-
Ability to provide informed consent, read and write English.
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions are excluded:
-
Dementia or evidence of mental incompetence which would preclude compliance with the protocol.
-
Severe diarrhea defined as 5 or more watery stools per day for at least 7 days.
-
Active uncontrolled systemic infections at the start of treatment.
-
Patients may not be entered for at least 2 weeks after acute infection.
-
Clinical or radiologic evidence of ascites or pleural effusions.
Patients with the following are excluded:
-
Obstruction to food intake or impaired digestive/absorptive functions.
-
Contraindications to megestrol acetate (poorly controlled hypertension or heart failure or deep vein thrombosis).
-
Inability to consent or be available for close follow-up.
-
Active systemic infections at the start of treatment.
-
Clinical or radiologic evidence of ascites or pleural effusions.
-
Patients who have been hospitalized or have suffered an exacerbation of their illness associated with weight loss within the past 2 weeks are excluded.
-
Menstruating female patients are excluded.
Prior Medication:
Excluded:
-
Corticosteroids.
-
Anabolic steroids.
-
Marijuana.
-
Megestrol acetate.
-
Patients who have been started on zidovudine (AZT) within 8 weeks. (Patients may have been previously treated with AZT and failed or may currently be receiving AZT for at least 8 weeks.)
Patients may not be started on any therapy designed to treat the underlying HIV infection or which may have a major impact on appetite and/or weight gain.
- Patients who have been started on zidovudine (AZT) within 8 weeks. (Patients may have been previously treated with AZT and failed or may currently be receiving AZT for at least 8 weeks.)
History of substance abuse and questionable current and future abstinence.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Dr Mark Goldstein | Los Angeles | California | United States | 90048 |
2 | Summitt Med Ctr / San Francisco Gen Hosp | Oakland | California | United States | 94609 |
3 | Palo Alto Veterans Adm Med Ctr / Stanford Univ | Palo Alto | California | United States | 94304 |
4 | Eisenhower Med Ctr | Rancho Mirage | California | United States | 92270 |
5 | UCD Med Ctr | Sacramento | California | United States | 95817 |
6 | San Francisco AIDS Clinic / San Francisco Gen Hosp | San Francisco | California | United States | 941102859 |
7 | San Francisco Veterans Administration Med Ctr | San Francisco | California | United States | 94121 |
8 | Denver Public Health Dept | Denver | Colorado | United States | 80204 |
9 | Miami Veterans Administration Med Ctr | Miami | Florida | United States | 33125 |
10 | Univ of South Florida | Tampa | Florida | United States | 33612 |
11 | Northwestern Univ Med School | Chicago | Illinois | United States | 60611 |
12 | Mem Sloan - Kettering Cancer Ctr | New York | New York | United States | 10021 |
13 | SUNY / Health Sciences Ctr at Syracuse | Syracuse | New York | United States | 13210 |
14 | Northwest Family Ctr at the Harbor View Med Ctr | Seattle | Washington | United States | 98104 |
Sponsors and Collaborators
- Bristol-Myers Squibb
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- 025B
- MEG8809